Latest Health stories from Life.
Recent developments highlight significant progress in targeting KRAS, a key player in cancer treatment, alongside other notable biotech news including the Breakthrough Prize winners.
In recent pharmaceutical news, Trump has shown support for psychedelic treatment options while discussions continue regarding the future of weight-loss drugs.
Recent discussions highlight the effects of cannabis on adolescent brain development, alongside updates on the CDC director nominee and a measles outbreak.
Recent findings suggest that prolonged use of a drug from Nektar Therapeutics may encourage hair growth in individuals suffering from alopecia.
A prominent animal rights organization has raised concerns that Pfizer may not be adhering to its own established standards regarding the treatment of research monkeys.
Transgender adults are facing increasing difficulties in accessing necessary healthcare due to state restrictions, previous administration policies, and declining public support.
As measles outbreaks continue, families with immunocompromised members face challenging decisions about safety and health.
Pharmacy benefit managers (PBMs) are opposing a significant proposal aimed at increasing transparency in drug pricing, claiming it may be illegal.
The American Association of Cancer Researchers' annual meeting showcases significant advancements in the development of KRAS-targeting therapies, particularly by Revolution Medicines.
Despite a notable increase in Medicare Advantage spending in Puerto Rico, the expected improvements in plan quality have not materialized.
The latest issue of Health Affairs delves into critical topics such as drug pricing strategies, the role of behavioral health, and hospital policies.
The first year of the ACO program aimed at enhancing equity and community health has shown promising results, according to Health Affairs.
A recent study investigates how the COVID-19 pandemic has influenced mortality rates from non-COVID-19 causes in the United States between 2020 and 2024.
A recent analysis explores how changing patient cost-sharing practices are affecting the financial stability of both urban and rural hospitals.
A recent study highlights a notable decline in hospital utilization in Maryland, showing an 11 percentage point decrease compared to other states from 2013 to 2023.
A recent analysis highlights the trends in national spending on mental health and substance use disorder treatment from 2000 to 2021, reflecting case growth over the years.
The pancreatic cancer drug Daraxonrasib from Revolution Medicines is reportedly achieving remarkable results, with some patients experiencing doubled survival times.
In a recent directive, Trump has called on federal agencies to expedite access to psychedelic treatments and reconsider their classification as controlled substances.
The podcast 'Why Should I Trust You?' emphasizes the need for communication between MAHA and public health, highlighting the stakes involved.
While there is a sense of optimism regarding Trump's choice for the CDC, employees express a cautious outlook, especially concerning RFK Jr.'s involvement.